Drawing for Serial No. 88343418

USPTO serial 88343418

Serial No. 88343418

Reviewed by CopyMark Law Group

Reg. 5839842Status 702Registered
Filing date
Status date
Registration date
Aug 20, 2019
Examiner
PERKINS, ELLEN J
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with Serial No. 88343418?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Phillip Barengolts

Phillip Barengolts Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP125 S. Wacker DriveSuite 2050Chicago, IL 60606-4450

Goods and services

ClassDescriptionStatusFirst use
042Software as a service featuring software for designing laboratory experiments, for running laboratory experiments, and for reviewing laboratory experiment controls, equipment, and environmental data ; software as a service featuring software for reviewing laboratory experiment results; software as a service featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines; software as a service featuring software for scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and medical devices; software as a service featuring software for biopharmaceutical research design and scientific testing services; software as a service featuring software for product safety testing for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; software as a service featuring software for toxicological safety testing services for pharmaceuticals, chemicals, and consumer products; software as a service for developing quality control and custom assays; software as a service for remotely deploying quality control and custom assays; software as a service for remotely managing the performance of quality control and custom assays; software as a service featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; and software as a service for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experimentsACTIVEJul 19, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 14, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 14, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 14, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 25, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Aug 20, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 7, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 7, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 7, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 7, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 20, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 4, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 28, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2019DOCKASSIGNED TO EXAMINER—
Apr 5, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 4, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 21, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance